Lipocine
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-48-4.572.14
Price/Sales ratio
15.647.775.02
Earnings per Share (EPS)
$-0.06$-0.63$1.34

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.28-11.64-3.53-3.27-2.36-0.76-3.57-87.70-3.14-0.89-2.57-0.76
Price/Sales ratio
N/AN/AN/AN/A64.3860.44N/A3.4467.61-5.1555.3760.44
Price/Book Value ratio
2.545.052.583.622.921.584.891.220.940.720.771.58
Price/Cash Flow ratio
-3.87-13.81-3.67-4.11-2.28-0.85-4.90-12.61-2.82-1.23-2.31-0.85
Price/Free Cash Flow ratio
-3.85-13.78-3.65-4.11-2.28-0.85-4.90-12.59-2.79-1.23-2.28-0.85
Price/Earnings Growth ratio
-0.290.370.58-4.450.040.080.140.90-0.00-0.010.000.08
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A100%100%N/A100%100%100%-1233.78%100%
Operating Profit Margin
N/AN/AN/AN/A-2646.02%-7818.83%N/A19.48%-2423.87%628.97%-2423.87%-2646.02%
Pretax Profit Margin
N/AN/AN/AN/A-2723.94%-7883.59%N/A-3.92%-2151.59%573.56%-2151.59%-2723.94%
Net Profit Margin
N/AN/AN/AN/A-2724.10%-7883.71%N/A-3.93%-2151.72%573.59%-2151.72%-2724.10%
Effective Tax Rate
-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.00%-0.03%-0.00%-0.00%-0.00%-0.00%
Return on Assets
-72.77%-40.12%-69.38%-82.85%-55.91%-66.16%-82.69%-1.20%-28.65%-71.09%-28.65%-55.91%
Return On Equity
-77.28%-43.36%-72.92%-110.55%-123.6%-206.86%-136.65%-1.39%-30.19%-80.27%-27.66%-123.6%
Return on Capital Employed
-77.69%-43.78%-70.94%-111.79%-69.22%-87.79%-95.88%6.71%-33.79%-88.02%-33.79%-69.22%
Liquidity Ratios
Current Ratio
17.0713.2320.513.974.633.953.84N/AN/AN/A20.344.63
Quick Ratio
17.0713.2320.513.974.632.943.088.2520.348.6819.774.63
Cash ratio
16.935.894.190.501.791.952.910.521.871.811.871.79
Days of Sales Outstanding
N/AN/AN/AN/A32.8436.55N/A5.59481.69-6.69481.6932.84
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A118.77N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A32.86N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A448.83N/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.490.360.220.04N/AN/A0.050.36
Debt Equity Ratio
N/AN/AN/AN/A1.081.130.360.05N/AN/A0.051.13
Long-term Debt to Capitalization
N/AN/AN/AN/A0.420.370.12N/AN/AN/AN/A0.37
Total Debt to Capitalization
N/AN/AN/AN/A0.520.530.260.04N/AN/AN/A0.53
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-46.54N/AN/AN/A-24.82N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A-1.17-1.63-2.73-1.90N/AN/AN/A-1.17
Company Equity Multiplier
1.061.081.051.332.213.121.651.151.051.121.053.12
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-28.21-70.70N/A-0.27-23.934.16-23.93-28.21
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.0011111.001.011.001.011
Cash Flow Coverage Ratio
N/AN/AN/AN/A-1.17-1.63-2.73-1.90N/AN/AN/A-1.17
Short Term Coverage Ratio
N/AN/AN/AN/A-3.62-3.49-4.59-1.90N/AN/AN/A-3.62
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A